Clinical Trial Update: Evaluation of Sentinel Lymph Nodes in Head and Neck Squamous Cell Carcinoma [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating sentinel lymph node assessment in head and neck squamous cell carcinoma was terminated; results were posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma

Drugs mentioned

• Lymphoseek (tilmanocept)

Snippet

Sponsor: Navidea Biopharmaceuticals | Conditions: Head and Neck Squamous Cell Carcinoma (HNSCC) | Phase 3 | Status: TERMINATED | Results posted: 2014-08-08